Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation

Podobne knjige/članki

• Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
  od: Steinbicker, Andrea U., et al.
  Izdano: (2011)
• Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency
  od: Malhotra, Rajeev, et al.
  Izdano: (2015)
• BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism
  od: Mayeur, Claire, et al.
  Izdano: (2014)
• Bone morphogenetic protein signaling in inflammation
  od: Wu, David H, et al.
  Izdano: (2019)
• Deletion of the Sequence Encoding the Tail Domain of the Bone Morphogenetic Protein type 2 Receptor Reveals a Bone Morphogenetic Protein 7-Specific Gain of Function
  od: Leyton, Patricio A., et al.
  Izdano: (2013)